February 11, 2005
* Visx Inc., the Santa Clara, Calif.-based maker of laser vision correction equipment, reported a lower fourth-quarter profit because of merger-related expenses. Visx, which in November agreed to be acquired by Advanced Medical Optics Inc., posted a net profit of $5.9 million, or 11 cents a share, compared with $8.8 million, or 17 cents, a year earlier. Revenue rose 6% to $40.4 million.
May 5, 2000 |
Visx Inc., the No. 1 maker of lasers used to correct vision, said it will take a charge of about 12 cents a share against second-quarter earnings to settle antitrust and patent infringement lawsuits. The company said it paid about $12 million to settle antitrust claims made by eye-surgery and laser companies and a Texas physician who challenged the merits of one of Visx's patents. Shares of Visx have fallen 71% in the last year. The shares closed off 94 cents at $16.81 on Nasdaq.
July 29, 2000 |
Visx Inc., a maker of lasers used to correct vision, said longtime corporate raider Carl Icahn has filed to acquire up to 15% of its shares. Visx, based in Santa Clara, Calif., also said its board has adopted a stockholder rights plan. The rights go into effect only if a person or group acquires ownership of 10% or more of the company's common stock or commences a tender or exchange offer.
April 24, 2001 |
Visx Inc., the biggest maker of lasers used to correct vision, asked financier Carl Icahn to present details of his $1.84-billion buyout proposal to its board. Icahn, who has a 9.9% stake and is trying to oust the board and sell the Santa Clara company, on Friday offered $32 a share, a 54% premium to the shares' closing price the day before the proposal.
June 9, 1998 |
Visx Inc. said it will pay Summit Technology Inc. $35 million as the medical-laser companies settle lawsuits against each other and end their partnership. Santa Clara-based Visx and Summit, of Waltham, Mass., make lasers used to treat eye problems such as nearsightedness and farsightedness. Under their 1992 agreement, they were paying into a partnership and sharing revenue from eye operations using their lasers. The settlement ends months of legal wrangling over royalty payments.
December 11, 2000 |
Visx Inc., the No. 1 maker of excimer lasers, said it is studying ways to boost the company's stock price, including a possible sale or merger. Visx hired Goldman, Sachs & Co. as financial advisor earlier this year, the company said in a release distributed by Business Wire. Chief Executive Mark Logan sent a letter to shareholders last week saying other options include an acquisition or alliance. The company's shares have plunged 71% this year, cutting its market value to about $897 million.